Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the efficacy and safety of the combination valsartan with
hydrochlorothiazide and amlodipine in hypertensive patients previously treated with valsartan
with hydrochlorothiazide and remaining uncontrolled. A naturalistic approach will be taken
comparing two different possible ways to achieve the higher dosage of the triple combination,
i.e. 160 mg of valsartan and 25 mg of hydrochlorothiazide with amlodipine 10 mg.